141 related articles for article (PubMed ID: 3486292)
1. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
[TBL] [Abstract][Full Text] [Related]
2. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
Lever OW; Bell LN; McGuire HM; Ferone R
J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
[TBL] [Abstract][Full Text] [Related]
3. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
Thijssen HH
J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
[TBL] [Abstract][Full Text] [Related]
4. The effect of mafenide on dihydropteroate synthase.
Eagon RG; McManus AT
J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
[TBL] [Abstract][Full Text] [Related]
5. Phosphanilic acid inhibits dihydropteroate synthase.
Eagon RG; McManus AT
Antimicrob Agents Chemother; 1989 Nov; 33(11):1936-8. PubMed ID: 2514624
[TBL] [Abstract][Full Text] [Related]
6. P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
Seydel JK; Butte W
J Med Chem; 1977 Mar; 20(3):439-47. PubMed ID: 321779
[TBL] [Abstract][Full Text] [Related]
7. Cell-free dihydropteroate synthetase activity: its use to investigate the relationship between structure and activity of p-aminobenzoic derivatives.
Thijssen HH
Methods Enzymol; 1980; 66():570-6. PubMed ID: 6990197
[No Abstract] [Full Text] [Related]
8. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
Kovacs JA; Powell F; Voeller D; Allegra CJ
Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
[TBL] [Abstract][Full Text] [Related]
9. Potential antiatherosclerotic agents. 4. [(Functionalized-alkyl)amino]benzoic acid analogues of cetaben.
DeVries VG; Largis EE; Miner TG; Shepherd RG; Upeslacis J
J Med Chem; 1983 Oct; 26(10):1411-21. PubMed ID: 6604818
[TBL] [Abstract][Full Text] [Related]
10. Potential antiatherosclerotic agents. 3. Substituted benzoic and non benzoic acid analogues of cetaben.
Albright JD; DeVries VG; Du MT; Largis EE; Miner TG; Reich MF; Shepherd RG
J Med Chem; 1983 Oct; 26(10):1393-411. PubMed ID: 6604817
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog.
Swedberg G; Castensson S; Sköld O
J Bacteriol; 1979 Jan; 137(1):129-36. PubMed ID: 368012
[TBL] [Abstract][Full Text] [Related]
12. PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity.
Saavedra JE; Srinivasan A; Buzard GS; Davies KM; Waterhouse DJ; Inami K; Wilde TC; Citro ML; Cuellar M; Deschamps JR; Parrish D; Shami PJ; Findlay VJ; Townsend DM; Tew KD; Singh S; Jia L; Ji X; Keefer LK
J Med Chem; 2006 Feb; 49(3):1157-64. PubMed ID: 16451080
[TBL] [Abstract][Full Text] [Related]
13. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.
De Benedetti PG; Iarossi D; Folli U; Frassineti C; Menziani MC; Cennamo C
J Med Chem; 1989 Oct; 32(10):2396-9. PubMed ID: 2677378
[TBL] [Abstract][Full Text] [Related]
15. Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino) benzoic acid analogues of cetaben.
Albright JD; DeVries VG; Largis EE; Miner TG; Reich MF; Schaffer SA; Shepherd RG; Upeslacis J
J Med Chem; 1983 Oct; 26(10):1378-93. PubMed ID: 6604816
[TBL] [Abstract][Full Text] [Related]
16. Targeting methanopterin biosynthesis to inhibit methanogenesis.
Dumitru R; Palencia H; Schroeder SD; DeMontigny BA; Takacs JM; Rasche ME; Miner JL; Ragsdale SW
Appl Environ Microbiol; 2003 Dec; 69(12):7236-41. PubMed ID: 14660371
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.
De Benedetti PG; Iarossi D; Menziani C; Caiolfa V; Frassineti C; Cennamo C
J Med Chem; 1987 Mar; 30(3):459-64. PubMed ID: 3546688
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships in dihydropteroate synthase inhibition by sulfanilamides. Comparison with the antibacterial activity.
De Benedetti PG; Rastelli A; Frassineti C; Cennamo C
J Med Chem; 1981 Apr; 24(4):454-7. PubMed ID: 7021831
[TBL] [Abstract][Full Text] [Related]
19. Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides.
Prabhu V; Lui H; King J
Phytochemistry; 1997 May; 45(1):23-7. PubMed ID: 9127492
[TBL] [Abstract][Full Text] [Related]
20. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
